Truist raised the firm’s price target on Centene (CNC) to $39 from $35 and keeps a Buy rating on the shares. The firm remains bullish on Centene following the company’s 8-K and conference presentation where the management reaffirmed FY25 adjusted EPS guidance of $1.75, while its commentary around second-half Medicaid margin improvement, Marketplace rate refiling, and Stars was also constructive, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- UnitedHealth price target raised to $395 from $325 at Morgan Stanley
- Centene price target raised to $35 from $33 at Barclays
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Kroger reports mixed Q2, U.S. CPI rises 0.4% in August: Morning Buzz
- Centene Stock (CNC) Soars on Reaffirmed Guidance